Skip to content

Use of Mustadi Kadha in Metabolic Disease

Evaluation of effect of Mustadi kashay on Insulin resistance in Metabolic syndrome W.S.R. to Santarpanjanya vyadhi- A single arm clinical trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087057
Enrollment
50
Registered
2025-05-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E888- Other specified metabolic disorders

Interventions

None listed

Sponsors

Dr. Prajakta Bharat Shirame
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient fulfilling diagnostic criteria.

Exclusion criteria

Exclusion criteria: History of Systemic illness such as tuberculosis, carcinoma and endocrine disorders like Cushing s syndrome. Patient having history of myocardial infarction or unstable angina.

Design outcomes

Primary

MeasureTime frame
To Assess The Effect Of Mustayadi Kashay In Subjective Parameters Of Metabolic Syndrome.Timepoint: 3 MONTHS

Secondary

MeasureTime frame
To assess the efficacy of Mustadi kashay on BSL fasting, serum Triglycerides, HDL cholesterol, waist circumference, Blood pressure. To assess the efficacy of Mustadi kashay on subjective parametersTimepoint: 3 MONTHS

Countries

India

Contacts

Public ContactDr Prajakta Bharat Shirame

G.D. Pol Foundation, YMT Ayurveda Medical college

vd.pravin09j@gmail.com9890902106

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026